VIALE, GIUSEPPE
 Distribuzione geografica
Continente #
EU - Europa 1.139
AS - Asia 5
SA - Sud America 2
NA - Nord America 1
Totale 1.147
Nazione #
IT - Italia 1.139
CN - Cina 4
BR - Brasile 2
US - Stati Uniti d'America 1
VN - Vietnam 1
Totale 1.147
Città #
Genova 598
Genoa 301
Rapallo 154
Vado Ligure 75
Bordighera 11
Beijing 2
Ashburn 1
Curitiba 1
Goianésia 1
Ho Chi Minh City 1
Totale 1.145
Nome #
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years 204
The Fatal Wound of Hector, According to a Drawing by Peter Paul Rubens Designed for Tapestry Weaving 165
Neoadjuvant treatment with trastuzumab and pertuzumab plus palbociclib and fulvestrant in HER2-positive, ER-positive breast cancer (NA-PHER2): An exploratory, open-label, phase 2 study 147
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials 136
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: Meta-analysis of individual patient data from ten randomised trials 133
Abstract S2-05: Characterization and clinical relevance of the genomic alterations defining lobular breast cancer: 129
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer 96
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age 90
Standard Anthracycline-based versus Docetaxel-Capecitabine in early high clinical and/or genomic risk breast cancer in the EORTC 10041/ BIG 3-04 MINDACT phase III trial 87
Totale 1.187
Categoria #
all - tutte 4.364
article - articoli 4.364
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.728


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202162 0 0 0 0 6 10 4 10 5 16 8 3
2021/2022121 10 5 10 11 3 12 6 24 10 10 6 14
2022/2023182 16 24 3 11 26 25 4 21 29 4 18 1
2023/202479 5 18 3 12 5 7 2 11 6 2 4 4
2024/2025211 13 16 9 7 17 24 23 39 9 6 31 17
2025/202680 31 13 15 21 0 0 0 0 0 0 0 0
Totale 1.187